Intel has gotten hammered in this bear market. However, long term investors might want to take a look at Intel and its new product--Intel® Health Guide. Intel Health Guide is a care management tool designed for health care professionals who manage patients with chronic conditions. The Intel Health Guide PHS6000 along with the online interface - the Intel Health Care Management Suite - allows clinicians to monitor patients in their homes and manage care remotely. This might turn out to be a very important product given the aging of the baby boomer generation. These kinds of products tend to get adopted slowly at first but as prices come down the market tends to broadens. This could be a wave of the future at Intel.So far I have not seen a cost-benefit analysis. But, if this turns out to be cost effective and lowers the cost of treating patients with chronic conditions it could be a big winner. The cost of identifying problems as they occur might be big enough to justify the cost of the this device. Long term investors should be taking a look at this and then deciding if Intel is a good long term portfolio fit.
New Intel device looks to innovate remote patient treatment
Patients looking for a more integrated approach to healthcare from home can now look to Intel to help manage their needs. The Intel Health Guide, which received FDA clearance in July of this year, is a patient-monitoring system with an online interface that allows doctors to keep track of their patient's health needs remotely.
With the tool, doctors can also send patients important reminders and take their vital signs, among other perks, without having to physically be with the patient. Currently, the plan is for the Intel Health Guide to be tested through organizations such as Aetna and Erickson Retirement Communities (to name two), with the emphasis on showing improvements for treating such conditions as diabetes, hypertension and heart failure.
Louis Burns, vice president and general manager of the Intel Digital Health Group, believes that the device is a big step forward in remote care, especially for homebound patients.
"Intel has spent years researching the needs of both caregivers and patients, and we are now moving to launch a series of products that will help extend care from the hospital to the home," he said. "Our products will help address the challenges of an aging population and rising rates of chronic disease."
Read the Intel Press Release
New Intel device looks to innovate remote patient treatment
Patients looking for a more integrated approach to healthcare from home can now look to Intel to help manage their needs. The Intel Health Guide, which received FDA clearance in July of this year, is a patient-monitoring system with an online interface that allows doctors to keep track of their patient's health needs remotely.
With the tool, doctors can also send patients important reminders and take their vital signs, among other perks, without having to physically be with the patient. Currently, the plan is for the Intel Health Guide to be tested through organizations such as Aetna and Erickson Retirement Communities (to name two), with the emphasis on showing improvements for treating such conditions as diabetes, hypertension and heart failure.
Louis Burns, vice president and general manager of the Intel Digital Health Group, believes that the device is a big step forward in remote care, especially for homebound patients.
"Intel has spent years researching the needs of both caregivers and patients, and we are now moving to launch a series of products that will help extend care from the hospital to the home," he said. "Our products will help address the challenges of an aging population and rising rates of chronic disease."
Read the Intel Press Release
No comments:
Post a Comment